Trial intelligence / Profile preview

Serum Phosphorus Optimization in ICU Weaning

NCT05682846Completed

Sponsor
Alexandria University
Start
May 2022
Primary completion
Feb 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of sodium glycerophosphate in respiratory failure (2 arms), sponsored by Alexandria University. Primary endpoints: The duration of mechanical ventilation at 4 months and Weaning from mechanical ventilation at 4 months. Started May 2022; status: completed.

02

Drugs

sodium glycerophosphate
03

Conditions

respiratory failure

Beyond the preview

Go deeper on NCT05682846.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05682846.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call